Zentalis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. 

CEO
Julia Marie Eastland
CEOJulia Marie Eastland
Employees
166
Employees166
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
166
Employees166

ZNTL Key Statistics

Market cap
103.41M
Market cap103.41M
Price-Earnings ratio
-0.65
Price-Earnings ratio-0.65
Dividend yield
—
Dividend yield—
Average volume
851.72K
Average volume851.72K
High today
$1.51
High today$1.51
Low today
$1.41
Low today$1.41
Open price
$1.50
Open price$1.50
Volume
545.61K
Volume545.61K
52 Week high
$13.24
52 Week high$13.24
52 Week low
$1.01
52 Week low$1.01

Analyst ratings

60%

of 10 ratings
Buy
40%
Hold
60%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.